Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer

BACKGROUND: Patients with triple-negative breast cancer (TNBC) develop early recurrence. While PARP inhibitors (PARPi) have demonstrated potential in BRCA1/2-mutant (BRCA(MUT)) TNBC, durable responses will likely be achieved if PARPi are used in combination. It is plausible that sequential administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Beniey, Michèle, Hubert, Audrey, Haque, Takrima, Cotte, Alexia Karen, Béchir, Nelly, Zhang, Xiaomeng, Tran-Thanh, Danh, Hassan, Saima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147920/
https://www.ncbi.nlm.nih.gov/pubmed/36941406
http://dx.doi.org/10.1038/s41416-023-02226-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147920/
https://www.ncbi.nlm.nih.gov/pubmed/36941406
http://dx.doi.org/10.1038/s41416-023-02226-w

Ejemplares similares